The oral iron chelator deferasirox might improve posttransplant survival in allogeneic haematopoietic cell transplant (allo-HSCT) recipients with transfusional iron overload | AVESİS

Erciyes University Research Information System

The oral iron chelator deferasirox might improve posttransplant survival in allogeneic haematopoietic cell transplant (allo-HSCT) recipients with transfusional iron overload

Copy For Citation

Sivgin A., Baldane S., AKYOL G., KEKLIK M., KAYNAR L., KURNAZ F., ...More

39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), London, Canada, 7 - 10 April 2013, vol.48, (Summary Text)

Publication Type: Conference Paper / Summary Text
Volume: 48
City: London
Country: Canada
Erciyes University Affiliated: Yes